SGLT2 inhibitors improved health status in Black...

SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race.

Abstract

SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.

Authors

Pandey A; Van Spall HGC

Journal

Annals of Internal Medicine, Vol. 176, No. 9,

Publisher

American College of Physicians

Publication Date

September 1, 2023

DOI

10.7326/j23-0071

ISSN

1056-8751

Associated Experts

Harriette Van Spall

Associate Professor, Faculty of Health Sciences

Visit profile

Labels